Signaling to NF-κB

Genes and Development

Volumn 18, Issue 18, 2004, Pages 2195-2224

  Hayden, Matthew S ^a   Ghosh, Sankar ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

I B; NF B; Protein serine threonine; Signal transduction; Transcription factors

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; LYMPHOTOXIN BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; CHUK PROTEIN, HUMAN; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN;

GENETIC ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 4444376712     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1228704     Document Type: Review

References (365)

1. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., and Akira, S. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
2. Aggarwal, B.B. 2003. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 3: 745-756.
3. Agou, F., Ye, F., Goffinont, S., Courtois, G., Yamaoka, S., Israel, A., and Veron, M. 2002. NEMO trimerizes through its coiled-coil C-terminal domain. J. Biol. Chem. 277: 17464-17475.
4. Agou, F., Traincard, F., Vinolo, E., Courtois, G., Yamaoka, S., Israel, A., and Veron, M. 2004. The trimerization domain of NEMO is comprised of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J. Biol. Chem. 279: 27861-27869.
5. Akira, S. 2004. Toll-like receptor signaling. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.). Keystone Symposia, Snowbird Resort, Snowbird, UT.
6. Alcamo, E., Mizgerd, J.P., Horwitz, B.H., Bronson, R., Beg, A.A., Scott, M., Doerschuk, C.M., Hynes, R.O., and Baltimore, D. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κ B in leukocyte recruitment. J. Immunol. 167: 1592-1600.
7. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A., and Ben-Neriah, Y. 1995. Stimulation-dependent I κ B α phosphorylation marks the NF-κ B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. 92: 10599-10603.
8. Amir, R.E., Iwai, K., and Ciechanover, A. 2002. The NEDD8 pathway is essential for SCF(β-TrCP)-mediated ubiquitination and processing of the NF-κ B precursor p105. J. Biol. Chem. 277: 23253-23259.
9. Amir, R.E., Haecker, H., Karin, M., and Ciechanover, A. 2004. Mechanism of processing of the NF-κ B2 p100 precursor: Identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(β-TrCP) ubiquitin ligase. Oncogene 23: 2540-2547.
10. Anest, V., Hanson, J.L., Cogswell, P.C., Steinbrecher, K.A., Strahl, B.D., and Baldwin, A.S. 2003. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423: 659-663.
11. ras and protein kinase Cζ in primary endothelial cells. J. Biol. Chem. 274: 13594-13603.
12. Ashikawa, K., Shishodia, S., Fokt, I., Priebe, W., and Aggarwal, B.B. 2004. Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem. Pharmacol. 67: 353-364.
13. Barroga, C.F., Stevenson, J.K., Schwarz, E.M., and Verma, I.M. 1995. Constitutive phosphorylation of I κ B α by casein kinase II. Proc. Natl. Acad. Sci. 92: 7637-7641.
14. Barton, G.M. and Medzhitov, R. 2003. Toll-like receptor signaling pathways. Science 300: 1524-1525.
15. Beg, A.A., Sha, W.C., Bronson, R.T., and Baltimore, D. 1995a. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in I κB α-deficient mice. Genes & Dev. 9: 2736-2746.
16. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. 1995b. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170.
17. Beinke, S., Deka, J., Lang, V., Belich, M.P., Walker, P.A., Howell, S., Smerdon, S.J., Gamblin, S.J., and Ley, S.C. 2003. NF-κB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23: 4739-4752.
18. Belich, M.P., Salmeron, A., Johnston, L.H., and Ley, S.C. 1999. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105. Nature 397: 363-368.
19. Ben-Neriah, Y. 2002. Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3: 20-26.
20. -. 2003. Pinning NF-κB to the nucleus. Mol. Cell 12: 1344-1345.
21. Ben-Neriah, Y. and Schmitz, M.L. 2004. Of mice and men. EMBO Rep. 5: 668-673.
22. Bertin, J., Wang, L., Guo, Y., Jacobson, M.D., Poyet, J.L., Srinivasula, S.M., Merriam, S., DiStefano, P.S., and Alnemri, E.S. 2001. CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κ B. J. Biol Chem. 276: 11877-11882.
23. Bird, T.A., Schooley, K., Dower, S.K., Hagen, H., and Virca, G.D. 1997. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272: 32606-32612.
24. Bonizzi, G. and Karin, M. 2004. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
25. Bonnard, M., Mirtsos, C., Suzuki, S., Graham, K., Huang, J., Ng, M., Itie, A., Wakeham, A., Shahinian, A., Henzel, W.J., et al. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J. 19: 4976-4985.
26. Bonnet, M.C., Weil, R., Dam, E., Hovanessian, A.G., and Meurs, E.F. 2000. PKR stimulates NF-κB irrespective of its kinase function by interacting with the IκB kinase complex. Mol. Cell. Biol. 20: 4532-4542.
27. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K., and Siebenlist, U. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739.
28. Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., et al. 2004. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat. Cell Biol. 6: 97-105.
29. Brach, M.A., Hass, R., Sherman, M.L., Gunji, H., Weichselbaum, R., and Kufe, D. 1991. Ionizing radiation induces expression and binding activity of the nuclear factor κ B. J. Clin. Invest. 88: 691-695.
30. Bradley, J.R. and Pober, J.S. 2001. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491.
31. Brasier, A.R., Lu, M., Hai, T., Lu, Y., and Boldogh, I. 2001. NF-κ B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence. J. Biol. Chem. 276: 32080-32093.
32. Brummelkamp, T.R., Nijman, S.M., Dirac, A.M., and Bernards, R. 2003. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424: 797-801.
33. Bulut, Y., Faure, E., Thomas, L., Equils, O., and Arditi, M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167: 987-994.
34. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Gate, R., and Lo, D. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373: 531-536.
35. Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., and Volpe, F. 2000. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2: 346-351.
36. Burns, K., Janssens, S., Brissoni, B., Olivos, N., Beyaert, R., and Tschopp, J. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263-268.
37. Caamano, J.H., Perez, P., Lira, S.A., and Bravo, R. 1996. Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol. Cell. Biol. 16: 1342-1348.
38. Caamano, J.H., Rizzo, C.A., Durham, S.K., Barton, D.S., Raventos-Suarez, C., Snapper, C.M., and Bravo, R. 1998. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187: 185-196.
39. Campbell, K.J., Rocha, S., and Perkins, N.D. 2004. Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol. Cell 13: 853-865.
40. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D.V. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383: 443-446.
41. Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R., Schmidt, E.V., and Karin, M. 2001. IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107: 763-775.
42. Carrasco, D., Cheng, J., Lewin, A., Warr, G., Yang, H., Rizzo, C., Rosas, F., Snapper, C., and Bravo, R. 1998. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J. Exp. Med. 187: 973-984.
43. Chen, Z.J. 2004. Ubiquitin signaling in the NF-κB pathway. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.). Keystone Symposia, Snowbird Resort, Snowbird, UT.
44. Chen, L.F. and Greene, W.C. 2004. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell. Biol. 5: 392-401.
45. Chen, Z.J., Parent, L., and Maniatis, T. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862.
46. Chen, F.E., Huang, D.E., Chen, Y.Q., and Ghosh, G. 1998. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 391: 410-413.
47. Chen, Y.Q., Ghosh, S., and Ghosh, G. 1998. A novel DNA recognition mode by the NF-κB p65 homodimer. Nat. Struct. Biol. 5: 67-73.
48. Chen, L., Fischle, W., Verdin, E., and Greene, W.C. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653-1657.
49. Chen, G., Cao, P., and Goeddel, D.V. 2002. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol. Cell 9: 401-410.
50. Chen, L.F., Mu, Y., and Greene, W.C. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21: 6539-6548.
51. Cheng, J.D., Ryseck, R.P., Attar, R.M., Dambach, D., and Bravo, R. 1998. Functional redundancy of the nuclear factor κB inhibitors I κB α and I κB β. J. Exp. Med. 188: 1055-1062.
52. Chu, W.M., Ostertag, D., Li, Z.W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., and Karin, M. 1999. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11: 721-731.
53. Chung, J.Y., Park, Y.C., Ye, H., and Wu, H. 2002. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115: 679-688.
54. Claudio E., Brown, K., Park, S., Wang, H., and Siebenlist, U. 2002. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3: 958-965.
55. Cohen, L., Henzel, W.J., and Baeuerle, P.A. 1998. IKAP is a scaffold protein of the IκB kinase complex. Nature 395: 292-296.
56. Cohen, S., Orian, A., and Ciechanover, A. 2001. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ubiquitin-ligase binding domain. J. Biol. Chem. 276: 26769-26776.
57. Cohen, S., Achbert-Weiner, H., and Ciechanover, A. 2004. Dual effects of IκB kinase β-mediated phosphorylation on p105 Fate: SCF(β-TrCP)-dependent degradation and SCF(β-TrCP)-independent processing. Mol. Cell. Biol. 24: 475-486.
58. Connelly, M.A. and Marcu, K.B. 1995. CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell Mol. Biol. Res. 41: 537-549.
59. Cooper, J.T., Stroka, D.M., Brostjan, C., Palmetshofer, A., Bach, F.H., and Ferran, C. 1996. A20 blocks endothelial cell acti vation through a NF-κB-dependent mechanism. J. Biol. Chem. 271: 18068-18073.
60. D'Acquisto, F. and Ghosh, S. 2001. PACT and PKR: Turning on NF-κB in the absence of virus. Sci. STKE 2001: RE1.
61. Davis, M., Hatzubai, A., Andersen, J.S., Ben-Shushan, E., Fisher, G.Z., Yaron, A., Bauskin, A., Mercurio, F., Mann, M., and Ben-Neriah, Y. 2002. Pseudosubstrate regulation of the SCF(β-TrCP) ubiquitin ligase by hnRNP-U. Genes & Dev. 16: 439-451.
62. Dejardin, E., Droin, N.M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z.W., Karin, M., Ware, C.F., and Green, D.R. 2002. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17: 525-535.
63. Delhase, M. and Karin, M. 1999. The I κB kinase: A master regulator of NF-κB, innate immunity, and epidermal differentiation. Cold Spring Harb. Symp. Quant. Biol. 64: 491-503.
64. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. 1999. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284: 309-313.
65. Dempsey, P.W., Doyle, S.E., He, J.Q., and Cheng, G. 2003. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14: 193-209.
66. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z.J. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
67. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D.U., Jin, R., Jones, J., Cong, R., and Franzoso, G. 2001. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
68. Desterro, J.M., Rodriguez, M.S., and Hay, R.T. 1998. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2: 233-239.
69. Devary, Y., Rosette, C., DiDonato, J.A., and Karin, M. 1993. NF-κ B activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445.
70. Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M., and Liu, Z. 2000. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12: 419-429.
71. Devin, A., Lin, Y., Yamaoka, S., Li, Z., Karin, M., and Liu, Z. 2001. The α and β subunits of IκB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. Mol. Cell. Biol. 21: 3986-3994.
72. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., and Karin, M. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16: 1295-1304.
73. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
74. Dobrzanski, P., Ryseck, R.P., and Bravo, R. 1993. Both N- and C-terminal domains of RelB are required for full transactivation: Role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13: 1572-1582.
75. -. 1994. Differential interactions of Rel-NF-κB complexes with I κB α determine pools of constitutive and inducible NF-κB activity. EMBO J. 13: 4608-4616.
76. Doi, T.S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y. 1997. NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185: 953-961.
77. Doi, T.S., Marino, M.W., Takahashi, T., Yoshida, T., Sakakura, T., Old, L.J., and Obata, Y. 1999. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. 96: 2994-2999.
78. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., et al. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083.
79. Dunne, A. and O'Neill, L.A. 2003. The interleukin-1 receptor/ Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci. STKE 2003: re3.
80. Duran, A., Diaz-Meco, M.T., and Moscat, J. 2003. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-κB transcriptional activation. EMBO J. 22: 3910-3918.
81. Duran, A., Serrano, M., Leitges, M., Flores, J.M., Picard, S., Brown, J.P., Moscat, J., and Diaz-Meco, M.T. 2004. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6: 303-309.
82. Eliopoulos, A.G., Dumitru, C.D., Wang, C.C., Cho, J., and Tsichlis, P.N. 2002. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21: 4831-4840.
83. Endres, R., Hacker, G., Brosch, I., and Pfeffer, K. 2003. Apparently normal tumor necrosis factor receptor 1 signaling in the absence of the silencer of death domains. Mol. Cell. Biol. 23: 6609-6617.
84. Eto, A., Muta, T., Yamazaki, S., and Takeshige, K. 2003. Essential roles for NF-κB and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I κB-ζ. Biochem. Biophys. Res. Commun. 301: 495-501.
85. Evans, P.C., Ovaa, H., Hamon, M., Kilshaw, P.J., Hamm, S., Bauer, S., Ploegh, H.L., and Smith, T.S. 2004. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378: 727-734.
86. Fan, C.M. and Maniatis, T. 1991. Generation of p50 subunit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354: 395-398.
87. Fisher, D.L., Mandart, E., and Doree, M. 2000. Hsp90 is required for c-Mos activation and biphasic MAP kinase activation in Xenopus oocytes. EMBO J. 19: 1516-1524.
88. Fitzgerald, K.A., Rowe, D.C., Barnes, B.J., Caffrey, D.R., Visintin, A., Latz, E., Monks, B., Pitha, P.M., and Golenbock, D.T. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198: 1043-1055.
89. Fong, A. and Sun, S.C. 2002. Genetic evidence for the essential role of β-transducin repeat-containing protein in the inducible processing of NF-κB2/p100. J. Biol Chem. 277: 22111-22114.
90. Franzoso, G., Bours, V., Azarenko, V., Park, S., Tomita-Yamaguchi, M., Kanno, T., Brown, K., and Siebenlist, U. 1993. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12: 3893-3901.
91. Franzoso, G., Carlson, L., Scharton-Kersten, T., Shores, E.W., Epstein, S., Grinberg, A., Tran, T., Shacter, E., Leonardi, A., Anver, M., et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6: 479-490.
92. Franzoso, G., Carlson, L., Poljak, L., Shores, E.W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., et al. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187: 147-159.
93. Fuchs, S.Y., Chen, A., Xiong, Y., Pan, Z.Q., and Ronai, Z. 1999. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin. Oncogene 18: 2039-2046.
94. Fujimoto, K., Yasuda, H., Sato, Y., and Yamamoto, K. 1995. A role for phosphorylation in the proteolytic processing of the human NF-κB1 precursor. Gene 165: 183-189.
95. Fujita, T., Nolan, G.P., Liou, H.C., Scott, M.L., and Baltimore, D. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes & Dev. 7: 1354-1363.
96. Gaide, O., Martinen, F., Micheau, O., Bonnet, D., Thome, M., and Tschopp, J. 2001. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation. FEBS Lett. 496: 121-127.
97. Gaide, O., Favier, B., Legler, D.F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., and Thome, M. 2002. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nat. Immunol. 3: 836-843.
98. Gerondakis, S., Morrice, N., Richardson, I.B., Wettenhall, R., Fecondo, J., and Grumont, R.J. 1993. The activity of a 70 kilodalton I κB molecule identical to the carboxyl terminus of the p105 NF-κB precursor is modulated by protein kinase A. Cell Growth Differ. 4: 617-627.
99. Ghosh, G. 2004. NF-κB biology at the interface of structure and biochemistry. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.). Keystone Symposia, Snowbird Resort, Snowbird, UT.
100. Ghosh, S. and Karin, M. 2002. Missing pieces in the NF-κB puzzle. Cell 109 Suppl: S81-S96.
101. Ghosh, G., van Duyne, G., Ghosh, S., and Sigler, P.B. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373: 303-310.
102. Ghosh, S., May, M.J., and Kopp, E.B. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
103. Goes, F.S. and Martin, J. 2001. Hsp90 chaperone complexes are required for the activity and stability of yeast protein kinases Mik1, Wee1 and Swe1. Eur. J. Biochem. 268: 2281-2289.
104. Grumont, R.J. and Gerondakis, S. 1994. Alternative splicing of RNA transcripts encoded by the murine p105 NF-κB gene generates I κB γ isoforms with different inhibitory activities. Proc. Natl. Acad. Sci. 91: 4367-4371.
105. Gu, W. and Roeder, R.G. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
106. Guo, Y.L., Baysal, K., Rang, B., Yang, L.J., and Williamson, J.R. 1998. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J. Biol. Chem. 273: 4027-4034.
107. Guo, B., Su, T.T., and Rawlings, D.J. 2004. Protein kinase C family functions in B-cell activation. Curr. Opin. Immunol. 16: 367-373.
108. Hara, H., Wada, T., Bakal, C., Kozieradzki, I., Suzuki, S., Suzuki, N., Nghiem, M., Griffiths, E.K., Krawczyk, C., Bauer, B., et al. 2003. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18: 763-775.
109. Hardy, M.P., McGettrick, A.F., and O'Neill, L.A. 2004. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon β) gene. Biochem. J. 380: 83-93.
110. Harhaj, E.W., Maggirwar, S.B., and Sun, S.C. 1996. Inhibition of p105 processing by NF-κB proteins in transiently transfected cells. Oncogene 12: 2385-2392.
111. Haruta, H., Kato, A., and Todokoro, K. 2001. Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs. J. Biol. Chem. 276: 12485-12488.
112. Hatada, E.N., Nieters, A., Wulczyn, F.G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T.W., and Scheidereit, C. 1992. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci. 89: 2489-2493.
113. Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M., Matsumoto, M., Hattori, K., Higashi, H., Nakano, H., Okumura, K., Onoe, K., et al. 1999. Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc. Natl. Acad. Sci. 96: 3859-3863.
114. Heilker, R., Freuler, F., Pulfer, R., Di Padova, F., and Eder, J. 1999. All three IκB isoforms and most Rel family members are stably associated with the IκB kinase 1/2 complex. Eur. J. Biochem. 259: 253-261.
115. Heissmeyer, V., Krappmann, D., Wulczyn, F.G., and Scheidereit, C. 1999. NF-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J. 18: 4766-4778.
116. Heissmeyer, V., Krappmann, D., Hatada, E.N., and Scheidereit, C. 2001. Shared pathways of IκB kinase-induced SCF(βTrCP)-mediated ubiquitination and degradation for the NF-κB precursor p105 and IκBα. Mol. Cell. Biol. 21: 1024-1035.
117. Hemmi, H., Takeuchi, O., Sato, S., Yamamoto, M., Kaisho, T., Sanjo, H., Kawai, T., Hoshino, K., Takeda, K., and Akira, S. 2004. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650.
118. Heusch, M., Lin, L., Geleziunas, R., and Greene, W.C. 1999. The generation of nfkb2 p52: Mechanism and efficiency. Oncogene 18: 6201-6208.
119. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., and Woodgett, J.R. 2000. Requirement for glycogen synthase kinase-3β in cell survival and NF- κB activation. Nature 406: 86-90.
120. Hoffmann, A., Levchenko, A., Scott, M.L., and Baltimore, D. 2002. The IκB-NF-κB signaling module: Temporal control and selective gene activation. Science 298: 1241-1245.
121. Hoffmann, A., Leung, T.H., and Baltimore, D. 2003. Genetic analysis of NF-κB/Rel transcription factors defines functional specificities. EMBO J. 22: 5530-5539.
122. Horng, T., Barton, G.M., Flavell, R.A., and Medzhitov, R. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420: 329-333.
123. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308.
124. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284: 316-320.
125. Hu, Y., Baud, V., Oga, T., Kim, K.I., Yoshida, K., and Karin, M. 2001. IKKα controls formation of the epidermis independently of NF-κB. Nature 410: 710-714.
126. Huang, T.T., Kudo, N., Yoshida, M., and Miyamoto, S. 2000. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/ IκBα complexes. Proc. Natl. Acad. Sci. 97: 1014-1019.
127. Huang, D.B., Chen, Y.Q., Ruetsche, M., Phelps, C.B., and Ghosh, G. 2001. X-Ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure (Camb.) 9: 669-678.
128. Huang, T.T., Feinberg, S.L., Suryanarayanan, S., and Miyamoto, S. 2002. The zinc finger domain of NEMO is selectively required for NF-κB activation by UV radiation and topoisomerase inhibitors. Mol. Cell. Biol. 22: 5813-5825.
129. Huang, T.T., Wuerzberger-Davis, S.M., Wu, Z.H., and Miyamoto, S. 2003. Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 115: 565-576.
130. Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.G., and Su, B. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5: 98-103.
131. Hueber, A.O. 2003. Role of membrane microdomain rafts in TNFR-mediated signal transduction. Cell Death Differ. 10: 7-9.
132. Hur, G.M., Lewis, J., Yang, Q., Lin, Y., Nakano, H., Nedospasov, S., and Liu, Z.G. 2003. The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation. Genes & Dev. 17: 873-882.
133. Huxford, T., Huang, D.E., Malek, S., and Ghosh, G. 1998. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell 95: 759-770.
134. Huynh, Q.K., Boddupalli, H., Rouw, S.A., Koboldt, C.M., Hall, T., Sommers, C., Hauser, S.D., Pierce, J.L., Combs, R.G., Reitz, B.A., et al. 2000. Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity. J. Biol. Chem. 275: 25883-25891.
135. Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P.C., Chen, F.F., Ogura, Y., and Nunez, G. 2000. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275: 27823-27831.
136. Inoue, J., Kerr, L.D., Kakizuka, A., and Verma, I.M. 1992. I κB γ, a 70 kD protein identical to the C-terminal half of p110 NF-κB: A new member of the I κB family. Cell 68: 1109-1120.
137. Ishii, T., Kwon, H., Hiscott, J., Mosialos, G., and Koromilas, A.E. 2001. Activation of the I êÂákinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR. Oncogene 20:1900-1912.
138. Israel, A. 2004. Biochemical and genetic analysis of the NF-κB signaling pathway. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.). Keystone Symposia, Snowbird Resort, Snowbird, UT.
139. Jaattela, M., Mouritzen, H., Elling, F., and Bastholm, L. 1996. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156: 1166-1173.
140. Jacobs, M.D. and Harrison, S.C. 1998. Structure of an IκBα/NF-κB complex. Cell 95: 749-758.
141. Janeway Jr., C.A. and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
142. Janssens, S. and Beyaert, R. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11: 293-302.
143. Janssens, S., Burns, K., Tschopp, J., and Beyaert, R. 2002. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr. Biol. 12:467-471.
144. Janssens, S., Burns, K., Vercammen, E., Tschopp, J., and Beyaert, R. 2003. MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression. FEBS Lett. 548: 103-107.
145. Jiang, Y., Woronicz, J.D., Liu, W., and Goeddel, D.V. 1999. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283: 543-546.
146. Jin, R., De Smaele, E., Zazzeroni, F., Nguyen, D.U., Papa, S., Jones, J., Cox, C., Gelinas, C., and Franzoso, G. 2002. Regulation of the gadd45β promoter by NF-κB. DNA Cell Biol. 21: 491-503.
147. Johnson, C., Van Antwerp, D., and Hope, T.J. 1999. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J. 18: 6682-6693.
148. Kanamori, M., Kai, C., Hayashizaki, Y., and Suzuki, H. 2002. NF-κB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. FEBS Lett. 532: 241-246.
149. Kane, L.P., Mollenauer, M.N., Xu, Z., Turck, C.W., and Weiss, A. 2002. Akt-dependent phosphorylation specifically regulates Cot induction of NF-κB-dependent transcription. Mol. Cell. Biol. 22: 5962-5974.
150. Karin, M. and Ben-Neriah, Y. 2000. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18: 621-663.
151. Karin, M., Yamamoto, Y., and Wang, Q.M. 2004. The IKK NF-κB system: A treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26.
152. Kato Jr., T., Delhase, M., Hoffmann, A., and Karin, M. 2003. CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response. Mol. Cell 12: 829-839.
153. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., and Akira, S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
154. Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., and Leder, P. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297-303.
155. Kelly, D., Campbell, J.I., King, T.P., Grant, G., Jansson, E.A., Coutts, A.G., Pettersson, S., and Conway, S. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat. Immunol. 5: 104-112.
156. Kerr, L.D., Duckett, C.S., Wamsley, P., Zhang, Q., Chiao, P., Nabel, G., McKeithan, T.W., Baeuerle, P.A., and Verma, I.M. 1992. The proto-oncogene bcl-3 encodes an I κB protein. Genes & Dev. 6: 2352-2363.
157. Khoshnan, A., Kempiak, S.J., Bennett, B.L., Bae, D., Xu, W., Manning, A.M., June, C.H., and Nel, A.E. 1999. Primary human CD4+ T cells contain heterogeneous I κ B kinase complexes: Role in activation of the IL-2 promoter. J. Immunol. 163: 5444-5452.
158. Khoshnan, A., Bae, D., Tindell, C.A., and Nel, A.E. 2000. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of κB factor kinase (IKK) complex plays a role in the activation of the NF-κB cascade by TCR and CD28. J. Immunol. 165: 6933-6940.
159. Kiernan, R., Bres, V., Ng, R.W., Coudart, M.P., El Messaoudi, S., Sardet, C., Jin, D.Y., Emiliani, S., and Benkirane, M. 2003. Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65. J. Biol Chem. 278: 2758-2766.
160. Kitamura, H., Kanehira, K., Okita, K., Morimatsu, M., and Saito, M. 2000. MAIL, a novel nuclear I κB protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485: 53-56.
161. Klement, J.F., Rice, N.R., Car, B.D., Abbondanzo, S.J., Powers, G.D., Bhatt, P.H., Chen, C.H., Rosen, C.A., and Stewart, C.L. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16: 2341-2349.
162. Knop, J. and Martin, M.U. 1999. Effects of IL-1 receptor-associated kinase (IRAK) expression on IL-1 signaling are independent of its kinase activity. FEBS Lett. 448: 81-85.
163. Kobayashi, K., Hernandez, L.D., Galan, J.E., Janeway Jr., C.A., Medzhitov, R., and Flavell, R.A. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
164. Komatsu, Y., Shibuya, H., Takeda, N., Ninomiya-Tsuji, J., Yasui, T., Miyado, K., Sekimoto, T., Ueno, N., Matsumoto, K., and Yamada, G. 2002. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech. Dev. 119: 239-249.
165. Kontgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev. 9: 1965-1977.
166. Kopp, E. and Medzhitov, R. 2003. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15: 396-401.
167. Kopp, E., Medzhitov, R., Carothers, J., Xiao, C., Douglas, I., Janeway, C.A., and Ghosh, S. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes & Dev. 13: 2059-2071.
168. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D., and Courtois, G. 2003. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424: 801-805.
169. Krappmann, D., Hatada, E.N., Tegethoff, S., Li, J., Klippel, A., Giese, K., Baeuerle, P.A., and Scheidereit, C. 2000. The I κ B kinase (IKK) complex is tripartite and contains IKK γ but not IKAP as a regular component. J. Biol Chem. 275: 29779-29787.
170. Kravchenko, V.V., Mathison, J.C., Schwamborn, K., Mercurio, F., and Ulevitch, R.J. 2003. IKKi/IKKε plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278: 26612-26619.
171. Kreuz, S., Siegmund, D., Scheurich, P., and Wajant, H. 2001. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 21: 3964-3973.
172. Krikos, A., Laherty, C.D., and Dixit, V.M. 1992. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol Chem. 267: 17971-17976.
173. Kroll, M., Margottin, F., Kohl, A., Renard, P., Durand, H., Concordet, J.P., Bachelerie, F., Arenzana-Seisdedos, F., and Benarous, R. 1999. Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP. J. Biol. Chem. 274: 7941-7945.
174. Kucharczak, J., Simmons, M.J., Fan, Y., and Gelinas, C. 2003. To be, or not to be: NF-κB is the answer-Role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22: 8961-8982.
175. Kumar, A., Haque, J., Lacoste, J., Hiscott, J., and Williams, B.R. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κ B by phosphorylating I κ B. Proc. Natl. Acad. Sci. 91: 6288-6292.
176. Kuwata, H., Watanabe, Y., Miyoshi, H., Yamamoto, M., Kaisho, T., Takeda, K., and Akira, S. 2003. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages. Blood 102: 4123-4129.
177. Kwak, Y.T., Guo, J., Shen, J., and Gaynor, R.B. 2000. Analysis of domains in the IKKα and IKKβ proteins that regulate their kinase activity. J. Biol Chem. 275: 14752-14759.
178. Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F., and Dixit, V.M. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem. 267: 24157-24160.
179. Lallena, M.J., Diaz-Meco, M.T., Bren, G., Paya, C.V., and Moscat, J. 1999. Activation of IκB kinase β by protein kinase C isoforms. Mol. Cell. Biol. 19: 2180-2188.
180. Lamb, J.A., Ventura, J.J., Hess, P., Flavell, R.A., and Davis, R.J. 2003. JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11: 1479-1489.
181. Lang, V., Janzen, J., Fischer, G.Z., Soneji, Y., Beinke, S., Salmeron, A., Allen, H., Hay, R.T., Ben-Neriah, Y., and Ley, S.C. 2003. βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23: 402-413.
182. Lee, S.H. and Hannink, M. 2002. Characterization of the nuclear import and export functions of IκBε. J. Biol. Chem. 277: 23358-23366.
183. Lee, F.S., Hagler, J., Chen, Z.J., and Maniatis, T. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222.
184. Lee, E.G., Boone, D.L., Chai, S., Libby, S.L., Chien, M., Lodolce, J.P., and Ma, A. 2000. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289: 2350-2354.
185. Legler, D.F., Micheau, O., Doucey, M.A., Tschopp, J., and Bron, C. 2003. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity 18: 655-664.
186. Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcia, J.F., Camacho, P., Diaz-Meco, M.T., Rennert, P.D., and Moscat, J. 2001. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol. Cell 8: 771-780.
187. Lernbecher, T., Kistler, B., and Wirth, T. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13: 4060-4069.
188. Li, X. 2004. Act1, a negative regulator in B cell survival. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.). Keystone Symposia, Snowbird Resort, Snowbird, UT.
189. Li, Z. and Nabel, G.J. 1997. A new member of the IκB protein family, IκBε, inhibits RelA (p65 (-mediated NF-κB transcription. Mol. Cell. Biol. 17: 6184-6190.
190. Li, N. and Karin, M. 1998. Ionizing radiation and short wave-length UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. 95: 13012-13017.
191. Li, Q. and Verma, I.M. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
192. Li, Q., Lu, Q., Hwang, J.Y., Buscher, D., Lee, K.F., Izpisua-Belmonte, J.C., and Verma, I.M. 1999a. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes & Dev. 13: 1322-1328.
193. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., and Verma, I.M. 1999b. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284: 321-325.
194. Li, X., Commane, M., Burns, C., Vithalani, K., Cao, Z., and Stark, G.R. 1999. Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol. Cell. Biol. 19: 4643-4652.
195. Li, Y., Rang, J., Friedman, J., Tarassishin, L., Ye, J., Kovalenko, A., Wallach, D., and Horwitz, M.S. 1999. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis. Proc. Natl. Acad. Sci. 96: 1042-1047.
196. Li, Z.W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. 1999. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J. Exp. Med. 189: 1839-1845.
197. Li, Q., Estepa, G., Memet, S., Israel, A., and Verma, I.M. 2000. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation. Genes & Dev. 14: 1729-1733.
198. Li, X., Commane, M., Nie, H., Hua, X., Chatterjee-Kishore, M., Wald, D., Haag, M., and Stark, G.R. 2000. Act1, an NF-κB-activating protein. Proc. Natl. Acad. Sci. 97: 10489-10493.
199. Li, N., Banin, S., Ouyang, H., Li, G.G., Courtois, G., Shiloh, Y., Karin, M., and Rotman, G. 2001. ATM is required for Iκ kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276: 8898-8903.
200. Liao, G. and Sun, S.C. 2003. Regulation of NF-κB2/p100 processing by its nuclear shuttling. Oncogene 22: 4868-4874.
201. Lin, L. and Ghosh, S. 1996. A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell Biol. 16: 2248-2254.
202. Lin, R., Beauparlant, P., Makris, C., Meloche, S., and Hiscott, J. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell Biol. 16: 1401-1409.
203. Lin, L., DeMartino, G.N., and Greene, W.C. 1998. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92:819-828.
204. Lin, X., Mu, Y., Cunningham Jr., E.T., Marcu, K.B., Geleziunas, R., and Greene, W.C. 1998. Molecular determinants of NF-κB-inducing kinase action. Mol. Cell. Biol. 18: 5899-5907.
205. Lin, X., Cunningham Jr., E.T., Mu, Y., Geleziunas, R., and Greene, W.C. 1999. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10: 271-280.
206. Ling, L., Cao, Z., and Goeddel, D.V. 1998. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. 95: 3792-3797.
207. Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes & Dev. 13: 1015-1024.
208. Lucas, P.C., McAllister-Lucas, L.M., and Nunez, G. 2004. NF-κB signaling in lymphocytes: A new cast of characters. J. Cell Sci. 117:31-39.
209. Lynch, O.T. and Gadina, M. 2004. Ubiquitination for activation: New directions in the NF-κB roadmap. Mol. Interv. 4: 144-146.
210. MacKichan, M.L., Logeat, F., and Israel, A. 1996. Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-κB. J. Biol Chem. 271: 6084-6091.
211. Makris, C., Godfrey, V.L., Krahn-Senftleben, G., Takahashi, T., Roberts, J.L., Schwarz, T., Feng, L., Johnson, R.S., and Karin, M. 2000. Female mice heterozygous for IKK γ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5: 969-979.
212. Makris, C., Roberts, J.L., and Karin, M. 2002. The carboxylterminal region of IκB kinase γ (IKK-γ) is required for full IKK activation. Mol. Cell. Biol. 22: 6573-6581.
213. Malek, S., Chen, Y., Huxford, T., and Ghosh, G. 2001. IκBβ, but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells. J. Biol. Chem. 276: 45225-45235.
214. Malek, S., Huang, D.B., Huxford, T., Ghosh, S., and Ghosh, G. 2003. X-Ray crystal structure of an IκBβ × NF-κB p65 homodimer complex. J. Biol Chem. 278: 23094-23100.
215. Mauro, C., Vito, P., Mellone, S., Pacifico, F., Chariot, A., Formisano, S., and Leonardi, A. 2003. Role of the adaptor protein CIKS in the activation of the IKK complex. Biochem. Biophys. Res. Commun. 309: 84-90.
216. May, M.J., D'Acquisto, F., Madge, L.A., Glockner, J., Pober, J.S., and Ghosh, S. 2000. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289: 1550-1554.
217. May, M.J., Marienfeld, R.B., and Ghosh, S. 2002. Characterization of the IκB-kinase NEMO binding domain. J. Biol. Chem. 277: 45992-46000.
218. McCarthy, J.V., Ni, J., and Dixit, V.M. 1998. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273: 16968-16975.
219. McElhinny, J.A., Trushin, S.A., Bren, G.D., Chester, N., and Paya, C.V. 1996. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16: 899-906.
220. McGettrick, A.F. and O'Neill, L.A. 2004. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol. Immunol. 41: 577-582.
221. McWhirter, S.M., Fitzgerald, K.A., Rosains, J., Rowe, D.C., Golenbock, D.T., and Maniatis, T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. 101: 233-238.
222. Mebius, R.E. 2003. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3: 292-303.
223. Melmed, G., Thomas, L.S., Lee, N., Tesfay, S.Y., Lukasek, K., Michelsen, K.S., Zhou, Y., Hu, B., Arditi, M., and Abreu, M.T. 2003. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: Implications for host-microbial interactions in the gut. J. Immunol. 170: 1406-1415.
224. Mercurio, F. 2004. IKK-related kinases as a target for drug therapy. In Keystone Symposium on NF-κB: Biology and pathology (eds. A.R. Ulrich et al.]. Keystone Symposia, Snowbird Resort, Snowbird, UT.
225. Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A., et al. 1997. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866.
226. Mercurio F., Murray, B.W., Shevchenko, A., Bennett, B.L., Young, D.B., Li, J.W., Pascual, G., Motiwala, A., Zhu, H., Mann, M., et al. 1999. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell Biol. 19: 1526-1538.
227. Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., and Tschopp, J. 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat. Immunol. 5: 503-507.
228. Miller, B.S. and Zandi, E. 2001. Complete reconstitution of human IκB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKγ on the complex activity in the absence of stimulation. J. Biol. Chem. 276: 36320-36326.
229. Miskolci, V., Castro-Alcaraz, S., Nguyen, P., Vancura, A., Davidson, D., and Vancurova, I. 2003. Okadaic acid induces sustained activation of NFκB and degradation of the nuclear IκBα in human neutrophils. Arch. Biochem. Biophys. 417: 44-52.
230. Mohan, N. and Meltz, M.L. 1994. Induction of nuclear factor κB after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat. Res. 140: 97-104.
231. Mosialos, G. and Gilmore, T.D. 1993. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene 8: 721-730.
232. Moustakas, A. and Heldin, C.H. 2003. Ecsit-ement on the cross-roads of Toll and BMP signal transduction. Genes & Dev. 17: 2855-2859.
233. Muller, C.W., Rey, F.A., Sodeoka, M., Verdine, G.L., and Harrison, S.C. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373: 311-317.
234. Muta, T., Yamazaki, S., Eto, A., Motoyama, M., and Takeshige, K. 2003. IκB-ζ a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-κ. J. Endotoxin Res. 9: 187-191.
235. Nakano, H., Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., et al. 1999. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl. Acad. Sci. 96: 9803-9808.
236. Nakayama, K., Hatakeyama, S., Maruyama, S., Kikuchi, A., Onoe, K., Good, R.A., and Nakayama, K.I. 2003. Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene. Proc. Natl. Acad. Sci. 100: 8752-8757.
237. Naumann, M. and Scheidereit, C. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J. 13: 4597-4607.
238. Naumann, M., Wulczyn, F.G., and Scheidereit, C. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J. 12: 213-222.
239. Neumann, M., Grieshammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza Jr., B.R., and Serfling, E. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14: 1991-2004.
240. Nolan, G.P., Fujita, T., Bhatia, K., Huppi, C., Liou, H.C., Scott, M.L., and Baltimore, D. 1993. The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13: 3557-3566.
241. O'Mahony, A.M., Montano, M., Van Beneden, K., Chen, L.F., and Greene, W.C. 2004. Human T-cell lymphotropic virus type 1 tax induction of biologically active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65. J. Biol Chem. 279: 18137-18145.
242. Orian, A., Schwartz, A.L., Israel, A., Whiteside, S., Kahana, C., and Ciechanover, A. 1999. Structural motifs involved in ubiquitin-mediated processing of the NF-κB precursor p105: Roles of the glycine-rich region and a downstream ubiquitination domain. Mol. Cell. Biol. 19: 3664-3673.
243. β-TrCP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase. EMBO J. 19: 2580-2591.
244. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., and Seya, T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4: 161-167.
245. Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785.
246. Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D.U., Pham, C.G., Nelsbach, A.M., Melis, T., et al. 2004. Gadd45 β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2. Nat. Cell Biol. 6: 146-153.
247. Paxian, S., Merkle, H., Riemann, M., Wilda, M., Adler, G., Hameister, H., Liptay, S., Pfeffer, K., and Schmid, R.M. 2002. Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2, and Bcl-3. Gastroenterology 122: 1853-1868.
248. Piret, B. and Piette, J. 1996. Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucleic Acids Res. 24: 4242-4248.
249. Poyet, J.L., Srinivasula, S.M., Lin, J.H., Fernandes-Alnemri, T., Yamaoka, S., Tsichlis, P.N., and Alnemri, E.S. 2000. Activation of the Iκ kinases by RIP via IKKγ/NEMO-mediated oligomerization. J. Biol Chem. 275: 37966-37977.
250. Prajapati, S., Verma, U., Yamamoto, Y., Kwak, Y.T., and Gaynor, R.B. 2004. Protein phosphatase 2Cβ association with the IκB kinase complex is involved in regulating NF-κB activity. J. Biol. Chem. 279: 1739-1746.
251. Qian, Y., Commane, M., Ninomiya-Tsuji, J., Matsumoto, K., and Li, X. 2001. IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NF-κB. J. Biol Chem. 276: 41661-41667.
252. Qian, Y., Zhao, Z., Jiang, Z., and Li, X. 2002. Role of NF-κB activator Act1 in CD40-mediated signaling in epithelial cells. Proc. Natl. Acad. Sci. 99: 9386-9391.
253. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., and Rothe, M. 1997. Identification and characterization of an IκB kinase. Cell 90: 373-383.
254. Rothwarf, D.M. and Karin, M. 1999. The NF-κB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci. STKE 1999: RE1.
255. Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. 1998. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395: 297-300.
256. Rudolph, D., Yeh, W.C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., and Mak, T.W. 2000. Severe liver degeneration and lack of NF-κB activation in NEMO/ IKKγ-deficient mice. Genes & Dev. 14: 854-862.
257. Ruefli-Brasse, A.A., French, D.M., and Dixit, V.M. 2003. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302: 1581-1584.
258. Ruefli-Brasse, A.A., Lee, W.P., Hurst, S., and Dixit, V.M. 2004. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-κB activation. J. Biol Chem. 279: 1570-1574.
259. Ruland, J. and Mak, T.W. 2003. Transducing signals from antigen receptors to nuclear factor κB. Immunol. Rev. 193:93-100.
260. Ruland, J., Duncan, G.S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D.G., Bouchard, D., Wakeham, A., Ohashi, P.S., et al. 2001. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104: 33-42.
261. Ryo, A., Suizu, F., Yoshida, Y., Perrem, K., Liou, Y.C., Wulf, G., Rottapel, R., Yamaoka, S., and Lu, K.P. 2003. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12: 1413-1426.
262. Ryseck, R.P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., and Bravo, R. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol Cell. Biol. 12: 674-684.
263. Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., and Saiki, I. 2003. Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAP5, and TAK1 signaling pathway. J. Biol. Chem. 278:36916-36923.
264. Salmeron, A., Janzen, J., Soneji, Y., Bump, N., Kamens, J., Allen, H., and Ley, S.C. 2001. Direct phosphorylation of NF-κB1 p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J. Biol Chem. 276: 22215-22222.
265. Sanjo, H., Takeda, K., Tsujimura, T., Ninomiya-Tsuji, J., Matsumoto, K., and Akira, S. 2003. TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling. Mol Cell. Biol. 23: 1231-1238.
266. Sanz, L., Sanchez, P., Lallena, M.J., Diaz-Meco, M.T., and Moscat, J. 1999. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18: 3044-3053.
267. Sanz, L., Diaz-Meco, M.T., Nakano, H., and Moscat, J. 2000. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway. EMBO J. 19: 1576-1586.
268. Sato, S., Fujita, N., and Tsuruo, T. 2000. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. 97: 10832-10837.
269. Scherer, D.C., Brockman, J.A., Chen, Z., Maniatis, T., and Ballard, D.W. 1995. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. 92: 11259-11263.
270. Schmidt, C., Peng, B., Li, Z., Sclabas, G.M., Fujioka, S., Niu, J., Schmidt-Supprian, M., Evans, D.B., Abbruzzese, J.L., and Chiao, P.J. 2003. Mechanisms of proinflammatory cytokine-induced biphasic NF-κB activation. Mol. Cell 12: 1287-1300.
271. Schmidt-Supprian, M., Bloch, W., Courtois, G., Addicks, K., Israel, A., Rajewsky, K., and Pasparakis, M. 2000. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell 5: 981-992.
272. Schwabe, R.F. and Brenner, D.A. 2002. Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G204-G211.
273. Schwarz, E.M., Krimpenfort, P., Berns, A., and Verma, I.M. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes & Dev. 11: 187-197.
274. Senftleben, U., Cao, Y., Xiao, G., Greten, F.R., Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.C., et al. 2001a. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293: 1495-1499.
275. Senftleben, U., Li, Z.W., Baud, V., and Karin, M. 2001b. IKKβ is essential for protecting T cells from TNFα-induced apoptosis. Immunity 14: 217-230.
276. Setoguchi, K., Misaki, Y., Terauchi, Y., Yamauchi, T., Kawahata, K., Kadowaki, T., and Yamamoto, K. 2001. Peroxisome proliferator-activated receptor-γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J. Clin. Invest. 108: 1667-1675.
277. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80: 321-330.
278. Sharma, S., tenOever, B.R., Grandvaux, N., Zhou, G.P., Lin, R., and Hiscott, J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 1148-1151.
279. Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T., and Honjo, T. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat. Genet. 22: 74-77.
280. Shu, H.B., Takeuchi, M., and Goeddel, D.V. 1996. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. 93: 13973-13978.
281. Shu, H.B., Halpin, D.R., and Goeddel, D.V. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6: 751-763.
282. Sigala, J.L., Bottero, V., Young, D.B., Shevchenko, A., Mercurio, F., and Verma, I.M. 2004. Activation of transcription factor NF-κB requires ELKS, an IκB kinase regulatory subunit. Science 304: 1963-1967.
283. Sil, A.K., Maeda, S., Sano, Y., Roop, D.R., and Karin, M. 2004. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664.
284. Silverman, N. and Maniatis, T. 2001. NF-κB signaling pathways in mammalian and insect innate immunity. Genes & Dev. 15: 2321-2342.
285. Simeoni, L., Kliche, S., Lindquist, J., and Schraven, B. 2004. Adaptors and linkers in T and B cells. Curr. Opin. Immunol. 16: 304-313.
286. Simeonidis, S., Liang, S., Chen, G., and Thanos, D. 1997. Cloning and functional characterization of mouse IκBε. Proc. Natl. Acad. Sci. 94: 14372-14377.
287. Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., and Stark, G.R. 2002. Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB(NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277: 3863-3869.
288. Snapper, C.M., Rosas, F.R., Zelazowski, P., Moorman, M.A., Kehry, M.R., Bravo, R., and Weih, F. 1996. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184: 1537-1541.
289. Solan, N.J., Miyoshi, H., Carmona, E.M., Bren, G.D., and Paya, C.V. 2002. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277: 1405-1418.
290. Song, H.Y., Rothe, M., and Goeddel, D.V. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. 93: 6721-6725.
291. Spencer, E., Jiang, J., and Chen, Z.J. 1999. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes & Dev. 13: 284-294.
292. Sun, Z., Arendt, C.W., Ellmeier, W., Schaeffer, E.M., Sunshine, M.J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P.L., et al. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
293. Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14:289-301.
294. Suzuki, H., Chiba, T., Kobayashi, M., Takeuchi, M., Suzuki, T., Ichiyama, A., Ikenoue, T., Omata, M., Furuichi, K., and Tanaka, K. 1999. IκBα ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/ WD40-repeat proteins, βTrCP1 and βTrCP2. Biochem. Biophys. Res. Commun. 256: 127-132.
295. Suzuki, H., Chiba, T., Suzuki, T., Fujita, T., Ikenoue, T., Omata, M., Furuichi, K., Shikama, H., and Tanaka, K. 2000. Homodimer of two F-box proteins βTrCP1 or βTrCP2 binds to IκBα for signal-dependent ubiquitination. J. Biol. Chem. 275: 2877-2884.
296. Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
297. Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T.W., Yagita, H., Okumura, K., et al. 2001. Critical roles of TRAF2 and TRAPS in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276: 36530-36534.
298. Takada, H., Chen, N.J., Mirtsos, C., Suzuki, S., Suzuki, N., Wakeham, A., Mak, T.W., and Yeh, W.C. 2003. Role of SODD in regulation of tumor necrosis factor responses. Mol. Cell. Biol. 23: 4026-4033.
299. Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., and Matsumoto, K. 2000. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5: 649-658.
300. Takaesu, G., Ninomiya-Tsuji, J., Kishida, S., Li, X., Stark, G.R., and Matsumoto, K. 2001. Interleukin-1 (IL-1] receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol. Cell. Biol. 21: 2475-2484.
301. Takaesu, G., Surabhi, R.M., Park, K.J., Ninomiya-Tsuji, J., Matsumoto, K., and Gaynor, R.B. 2003. TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 326: 105-115.
302. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. 1999. Limb and skin abnormalities in mice lacking IKKα. Science 284: 313-316.
303. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
304. Tam, W.F., Lee, L.H., Davis, L., and Sen, R. 2000. Cytoplasmic sequestration of rel proteins by IκBα requires CRM1-dependent nuclear export. Mol. Cell. Biol. 20: 2269-2284.
305. Tanaka, M., Fuentes, M.E., Yamaguchi, K., Durnin, M.H., Dalrymple, S.A., Hardy, K.L., and Goeddel, D.V. 1999. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10: 421-429.
306. Tang, G., Minemoto, Y., Dibling, B., Purcell, N.H., Li, Z., Karin, M., and Lin, A. 2001. Inhibition of JNK activation through NF-κB target genes. Nature 414: 313-317.
307. Tang, E.D., Inohara, N., Wang, C.Y., Nunez, G., and Guan, K.L. 2003. Roles for homotypic interactions and transautophosphorylation in IκB kinase (IKKβ] activation. J. Biol. Chem. 278: 38566-38570.
308. Tegethoff, S., Behlke, J., and Scheidereit, C. 2003. Tetrameric oligomerization of IκB kinase γ (IKKγ] is obligatory for IKK complex activity and NF-κB activation. Mol. Cell. Biol. 23:2029-2041.
309. Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., and Verma, I.M. 2003. IκB kinase-independent IκBα degradation pathway: Functional NF-κB activity and implications for cancer therapy. Mol. Cell Biol 23: 8070-8083.
310. Thomassen, E., Renshaw, B.R., and Sims, J.E. 1999. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11: 389-399.
311. Thome, M. 2004. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4: 348-359.
312. Ting, A.T., Pimentel-Muinos, F.X., and Seed, B. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189-6196.
313. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., and Mosialos, G. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424: 793-796.
314. Uhlik, M., Good, L., Xiao, G., Harhaj, E.W., Zandi, E., Karin, M., and Sun, S.C. 1998. NF-κB-inducing kinase and IκB kinase participate in human T-cell leukemia virus I Tax-mediated NF-κB activation. J. Biol. Chem. 273: 21132-21136.
315. Ventura, J.J., Kennedy, N.J., Lamb, J.A., Flavell, R.A., and Davis, R.J. 2003. c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23: 2871-2882.
316. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W., and Haegeman, G. 2003. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1]. EMBO J. 22: 1313-1324.
317. Wajant, H., Pfizenmaier, K., and Scheurich, P. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
318. Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J.E., Stark, G.R., and Li, X. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927.
319. Wang, D. and Baldwin Jr., A.S. 1998. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-α is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol Chem. 273: 29411-29416.
320. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin Jr., A.S. 1998. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
321. Wang, D., Westerheide, S.D., Hanson, J.L., and Baldwin Jr., A.S. 2000. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol Chem. 275: 32592-32597.
322. Wang, C., Deng, L., Hong, M., Akkaraju, G.R., Inoue, J., and Chen, Z.J. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351.
323. Waterfield, M.R., Zhang, M., Norman, L.P., and Sun, S.C. 2003. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11: 685-694.
324. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.P., Lira, S.A., and Bravo, R. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-340.
325. -/- double-knockout mice. J. Exp. Med. 185: 1359-1370.
326. Weil, R., Schwamborn, K., Alcover, A., Bessia, C., Di Bartolo, V., and Israel, A. 2003. Induction of the NF-κB cascade by recruitment of the scaffold molecule NEMO to the T cell receptor. Immunity 18: 13-26.
327. Wesche, H., Henzel, W.J., Shillinglaw, W., Li, S., and Cao, Z. 1997. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837-847.
328. Wesche, H., Gao, X., Li, X., Kirschning, C.J., Stark, G.R., and Cao, Z. 1999. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK] family. J. Biol. Chem. 274: 19403-19410.
329. Whiteside, S.T., Epinat, J.C., Rice, N.R., and Israel, A. 1997. IκBε, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16: 1413-1426.
330. Winston, J.T., Strack, P., Beer-Romero, P., Chu, C.Y., Elledge, S.J., and Harper, J.W. 1999. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes & Dev. 13: 270-283.
331. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. 1997. EκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278: 866-869.
332. Wu, C. and Ghosh, S. 1999. β-TrCP mediates the signal-induced ubiquitination of IκBβ. J. Biol Chem. 274: 29591-29594.
333. Wu, H. and Arron, J.R. 2003. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25: 1096-1105.
334. Wu, C. and Ghosh, S. 2003. Differential phosphorylation of the signal-responsive domain of IκBα and IκBβ by IκB kinases. J. Biol. Chem. 278: 31980-31987.
335. Wulczyn, F.G., Naumann, M., and Scheidereit, C. 1992. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358: 597-599.
336. Xia, Y., Makris, C., Su, B., Li, E., Yang, J., Nemerow, G.R., and Karin, M. 2000. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. 97: 5243-5248.
337. Xiao, G., Harhaj, E.W., and Sun, S.C. 2001. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7: 401-409.
338. Xiao, C., Shim, J.H., Kluppel, M., Zhang, S.S., Dong, C., Flavell, R.A., Fu, X.Y., Wrana, J.L., Hogan, B.L., and Ghosh, S. 2003. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes & Dev. 17: 2933-2949.
339. Xiao, G., Fong, A., and Sun, S.C. 2004. Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J Biol Chem. 279: 30099-30105.
340. Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., et al. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420: 324-329.
341. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., and Akira, S. 2003a. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
342. Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K., and Akira, S. 2003b. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4: 1144-1150.
343. Yamamoto, Y., Verma, U.N., Prajapati, S., Kwak, Y.T., and Gaynor, R.B. 2003. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423: 655-659.
344. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., Kirk, H.E., Kay, R.J., and Israel, A. 1998. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93: 1231-1240.
345. Yamazaki, S., Muta, T., and Takeshige, K. 2001. A novel IκB protein, IκB-ζ, induced by proinflammatory stimuli, negatively regulates nuclear factor-κB in the nuclei. J. Biol. Chem. 276: 27657-27662.
346. Yang, J., Lin, Y., Guo, Z., Cheng, J., Huang, J., Deng, L., Liao, W., Chen, Z., Liu, Z., and Su, B. 2001. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat. Immunol. 2: 620-624.
347. Yang, F., Tang, E., Guan, K., and Wang, C.Y. 2003. IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170: 5630-5635.
348. Yang, J., Xu, Z.P., Huang, Y., Hamrick, H.E., Duerksen-Hughes, P.J., and Yu, Y.N. 2004. ATM and ATR: Sensing DNA damage. World J. Gastroenterol. 10: 155-160.
349. Yaron, A., Gonen, H., Alkalay, I., Hatzubai, A., Jung, S., Beyth, S., Mercurio, F., Manning, A.M., Ciechanover, A., and Ben-Neriah, Y. 1997. Inhibition of NF-κ-B cellular function via specific targeting of the I-κ-B-ubiquitin ligase. EMBO J. 16: 6486-6494.
350. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A.M., Andersen, J.S., Mann, M., Mercurio, F., and Ben-Neriah, Y. 1998. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature 396: 590-594.
351. Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., et al. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
352. Yilmaz, Z.B., Weih, D.S., Sivakumar, V., and Weih, F. 2003. RelB is required for Peyer's patch development: Differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22: 121-130.
353. Yujiri, T., Ware, M., Widmann, C., Oyer, R., Russell, D., Chan, E., Zaitsu, Y., Clarke, P., Tyler, K., Oka, Y., et al. 2000. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-κB activation. Proc. Natl. Acad. Sci. 97: 7272-7277.
354. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.
355. Zandi, E., Chen, Y., and Karin, M. 1998. Direct phosphorylation of IκB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate. Science 281: 1360-1363.
356. Zelazowski, P., Carrasco, D., Rosas, F.R., Moorman, M.A., Bravo, R., and Snapper, C.M. 1997. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J. Immunol. 159: 3133-3139.
357. Zetoune, F.S., Murthy, A.R., Shao, Z., Hlaing, T., Zeidler, M.G., Li, Y., and Vincenz, C. 2001. A20 inhibits NF-κB activation downstream of multiple Map3 kinases and interacts with the IκB signalosome. Cytokine 15: 282-298.
358. Zhang, Y. and Chen, F. 2004. Reactive oxygen species (ROS), troublemakers between nuclear factor-κB (NF-κB] and c-Jun NH(2]-terminal kinase (JNK). Cancer Res. 64: 1902-1905.
359. Zhang, G. and Ghosh, S. 2002. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277: 7059-7065.
360. Zhang, S.Q., Kovalenko, A., Cantarella, G., and Wallach, D. 2000. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKγ] upon receptor stimulation. Immunity 12: 301-311.
361. Zhang, L., Wang, W., Hayashi, Y., Jester, J.V., Birk, D.E., Gao, M., Liu, C.Y., Kao, W.W., Karin, M., and Xia, Y. 2003. A role for MEK kinase 1 in TGF-β/activin-induced epithelium movement and embryonic eyelid closure. EMBO J. 22: 4443-4454.
362. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., and Ghosh, S. 1997. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.
363. Zhong, H., Voll, R.E., and Ghosh, S. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1: 661-671.
364. Zhong, H., May, M.J., Jimi, E., and Ghosh, S. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636.
365. Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., and Dixit, V.M. 2004. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 427: 167-171.